4.8.11.1Vertical
CPAP & BiPAP Systems
Positive airway pressure therapy devices for sleep apnea.
Market snapshot
These figures describe Respiratory & Sleep Devices (4.8.11), the segment that CPAP & BiPAP Systems sits within — not CPAP & BiPAP Systems on its own.
FragmentationConsolidatedEstimate
Within surgical & medical instruments (NAICS 339112) and electromedical; the Census Bureau does not split out respiratory/sleep, so the segment is not separately sized.
Business model & economics
Revenue model
Devices plus recurring masks, supplies, and consumables
Key economics
- Recurring revenue
- High
- EBITDA margin
- 20–30%
- Capex intensity
- High
recurring mask and supply replacement
Characteristics
- Sleep apnea is the largest piece of the category.
- Philips recall reshaped competitive share.
- Recurring mask-and-supply consumable revenue.
M&A deal context
Deal activityModerate
Who’s acquiring
- Respiratory & sleep strategics
- Diversified medtech platforms
- PE-backed device companies
What’s driving deals
- Share shifts following the Philips recall.
- Rising sleep-apnea diagnosis.
- Recurring-consumable economics.
Find CPAP & BiPAP Systems acquisition targets
Search Acquisera’s index for companies classified under CPAP & BiPAP Systems (4.8.11.1) and build a targeted deal pipeline.
Search companies